Clinical Trial Information Request for Protocol 20-144 Title A Phase Ib/II study of pembrolizumab, ibrutinib and rituximab in refractory/relapsed primary central nervous system lymphoma (PCNSL). PI Site Directions: Type your name, contact email and phone number (optional) into the boxes below then click Save to Submit your request for information about this study. Name Email Phone